← BIOLIFE SOLUTIONS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($6.9m) ($2.5m) $3.3m ($1.7m) $2.7m ($7.6m) ($139.8m) ($66.4m) ($20.2m) ($4.6m)
Net Income (Loss) Available to Common Stockholders, Basic — ($2.7m) $2.9m ($1.7m) $2.5m ($7.6m) ($139.8m) ($66.4m) — —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($8.0m) ($2.5m) — — — — — — — —
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — — — — — — — — ($11.4m) ($12.1m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent — — — — — — — — ($8.8m) $7.5m
Net Income (Loss) Attributable to Noncontrolling Interest ($1.2m) $0 — — — — — — — —
Depreciation, Depletion and Amortization $368k $339k $338k $718k $2.0m $4.7m $6.8m $7.1m $5.2m $2.3m
Depreciation $368k $339k $338k $718k $1.4m $2.9m $3.3m $3.6m $700k $800k
Amortization of Debt Issuance Costs $87k — — — — $121k $18k $13k $0 $0
Amortization of Intangible Assets — — — $1.1m $3.0m $8.2m $9.7m $5.2m $2.7m $263k
Deferred Income Tax Expense (Benefit) — — — ($1.5m) ($3.3m) ($20.1m) ($5.2m) ($62k) ($64k) $65k
Share-based Payment Arrangement, Noncash Expense $777k $1.3m $1.5m $3.0m $6.0m $14.0m $25.3m $31.7m $30.9m $23.0m
Share-based Payment Arrangement, Expense $777k $1.3m $1.5m $3.0m $6.0m $14.0m $25.3m $31.7m $16.5m $21.3m
Goodwill, Impairment Loss — — — — $0 $0 — — — —
Impairment of Intangible Assets (Excluding Goodwill) — — — — $0 $0 $110.4m $5.8m $0 $0
Gain (Loss) on Disposition of Business — — — — — — — — $15.9m $10.3m
Gain (Loss) on Disposition of Property Plant Equipment ($1k) $0 — $0 $0 ($482k) ($745k) ($633k) ($154k) ($11k)
Gain (Loss) on Extinguishment of Debt — — — — — $284k $0 $0 — —
Income (Loss) from Equity Method Investments — ($1.0m) ($672k) ($739k) $0 — — — — —
Income Tax Expense (Benefit) $0 $0 — ($1.5m) ($3.3m) ($20.1m) ($5.0m) $169k ($38k) $49k
Other Nonoperating Income (Expense) — — — — — $289k $704k $1.3m $497k $1.8m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $264k ($172k) $2.0m $290k $1.8m $10.1m $10.8m ($15.4m) $2.9m ($264k)
Increase (Decrease) in Inventories $291k $89k $1.7m $3.8m $629k ($114k) $6.6m $8.6m ($781k) $1.3m
Increase (Decrease) in Accounts Payable $233k $21k ($11k) $768k ($171k) $2.0m $414k ($8.4m) $26k ($2.1m)
Proceeds from Stock Options Exercised — — $508k $1.2m $1.5m $1.4m $323k $507k $202k $18k
Deconsolidation, Gain (Loss), Amount ($2.8m) $0 — — — — — — — —
Foreign Currency Transaction Gain (Loss), Unrealized — — — — $0 $0 $50k ($56k) ($18k) $0
Gain (Loss) on Investments — — — — $1.3m $0 $697k $0 ($4.1m) $0
General and Administrative Expense $4.6m $4.5m $6.0m $8.9m $14.6m $32.4m $47.7m $55.7m $40.5m $45.5m
Goodwill — — — $33.6m $58.4m $224.7m $224.7m $224.7m $212.3m $208.6m
Inventory Write-down — — — — — — — $5.7m — —
Investment Income, Interest — — — $506k $58k — — — — —
Nonoperating Income (Expense) ($3.2m) ($1.5m) ($396k) ($3.0m) $5.0m $6.2m $714k $4.6m ($4.3m) $4.5m
Operating Expenses $9.6m $7.8m $9.9m — — — — — — —
Revenue from Contract with Customer, Including Assessed Tax — — $19.7m $27.4m $48.1m $119.2m $161.8m $143.3m $82.3m $96.2m
Stock or Unit Option Plan Expense $612k $612k — — — — — — — —
Unrealized Gain (Loss) on Investments $451 $0 — — $0 $0 — — — —
Net Cash Provided by (Used in) Operating Activities ($4.3m) $605k $2.3m $1.2m $6.6m ($4.6m) ($8.5m) ($12.5m) $8.4m $20.1m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $144k $144k $500k $675k $2.0m $8.4m $10.4m $6.4m $3.2m $9.5m
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net — — — $10.1m $0 — $0 $0 — —
Payments to Acquire Investments $0 — $6.0m — — — — — — —
Net Cash Provided by (Used in) Investing Activities $393k ($144k) ($6.5m) ($27.0m) ($24.7m) ($13.2m) ($58.1m) $17.8m $58.3m ($71.5m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock — — — $0 $100.1m $0 $0 $10.2m $0 $0
Dividends Payable, Current — $106k — — — — — — — —
Proceeds from (Payments for) Other Financing Activities — — — ($159k) ($55k) ($124k) ($337k) $64k ($74k) $33k
Net Cash Provided by (Used in) Financing Activities $3.2m $4.8m $28.1m $1.6m $102.1m ($2.8m) $16.3m $10.6m ($6.8m) ($10.9m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — $5.3m $24.0m ($24.2m) $84.0m ($20.6m) ($50.3m) $15.9m $59.9m ($62.3m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — $90.5m $69.9m $19.5m $35.4m — —
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities — — — $0 $0 $452k $586k $1.9m $1.6m $762k
Income Taxes Paid, Net — — — — — — — — — $64k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.